The research comes as the Democratic Republic of the Congo (DRC) continues to battle the outbreak caused by Bundibugyo ebolavirus.

WHO experts say early evidence, including animal studies, suggests Ervebo could offer some protection—and the new trial will seek to establish whether that protection extends to…

The Democratic Republic of the Congo (DRC) will receive 70,000 doses of the Ervebo vaccine from the UN’s international vaccine coordination group (ICG) to protect frontline…